Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial
Registered in the Chinese Clinical Trial Register (ChiCTR2100042141).
Publications
View AllBiocompatible and antibacterial polymers for biomedical applications: a minireview
Abstract The global health crisis posed by antimicrobial resistance and biofilm-protected infections demands urgent development of biocompatible antibacterial materials. The tra...
Affiliated Researchers
Institution Info
- Type
- government
- Country
- CN
- Publications
- 2
- Citations
- 0
External Links
Identifiers
- ROR
- https://ror.org/002k3wk88